Published in J Clin Oncol on April 01, 2002
Clinical Database of Colorectal Robotic Surgery (ROBOT CR) | NCT04013152
The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg (2005) 2.03
Robotic total mesorectal excision for rectal cancer using four robotic arms. Surg Endosc (2007) 1.68
Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Virchows Arch (2006) 1.49
Robotic tumor-specific mesorectal excision of rectal cancer: short-term outcome of a pilot randomized trial. Surg Endosc (2008) 1.46
Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview. Int J Colorectal Dis (2011) 1.35
Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution. Tech Coloproctol (2013) 1.31
Application of objective clinical human reliability analysis (OCHRA) in assessment of technical performance in laparoscopic rectal cancer surgery. Tech Coloproctol (2016) 1.28
Total mesorectal excision: a comparison of oncological and functional outcomes between robotic and laparoscopic surgery for rectal cancer. Surg Endosc (2013) 1.20
Robotic transanal total mesorectal excision: a pilot study. Tech Coloproctol (2014) 1.17
The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment. J Clin Pathol (2006) 1.17
Transanal versus traditional laparoscopic total mesorectal excision for rectal carcinoma. Surg Endosc (2014) 1.16
Lymph node metastasis of carcinomas of transverse colon including flexures. Consideration of the extramesocolic lymph node stations. Int J Colorectal Dis (2014) 1.14
Comment on the editorial of Sautter-Bihl et al. in Strahlentherapie und Onkologie 2013 189:105-110. Strahlenther Onkol (2013) 1.08
Transanal total mesorectal excision for rectal carcinoma: short-term outcomes and experience after 80 cases. Surg Endosc (2015) 1.02
Transanal endoscopic total mesorectal excision: technical aspects of approaching the mesorectal plane from below--a preliminary report. Tech Coloproctol (2015) 1.02
Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer (2011) 1.02
Short-term clinical outcome of robot-assisted intersphincteric resection for low rectal cancer: a retrospective comparison with conventional laparoscopy. Surg Endosc (2012) 1.01
Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer (2016) 1.01
Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer. Tech Coloproctol (2016) 0.99
Transanal total mesorectal excision for rectal cancer. Surg Today (2015) 0.97
Electrophysiology-based quality assurance of nerve-sparing in laparoscopic rectal cancer surgery: Is it worth the effort? Surg Endosc (2016) 0.94
Robotic colorectal surgery. Yonsei Med J (2008) 0.93
Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up. J Gastrointest Surg (2009) 0.93
The Importance of the Pathologist's Role in Assessment of the Quality of the Mesorectum. Curr Colorectal Cancer Rep (2012) 0.92
Robotic-assisted transanal surgery for total mesorectal excision (RATS-TME): a description of a novel surgical approach with video demonstration. Tech Coloproctol (2013) 0.92
Comparison of intracorporeal single-stapled and double-stapled anastomosis in laparoscopic low anterior resection for rectal cancer: a case-control study. Int J Colorectal Dis (2012) 0.91
Evolving rectal cancer management in British Columbia. Can J Surg (2010) 0.90
Predictors of positive radial margin status in a population-based cohort of patients with rectal cancer. Curr Oncol (2008) 0.90
Local recurrence after curative resection in patients with colon and rectal cancers. Int J Colorectal Dis (2008) 0.89
Effects of change in rectal cancer management on outcomes in British Columbia. Can J Surg (2010) 0.88
Total mesorectal excision: technical aspects. Can J Surg (2004) 0.87
Laparoscopic vs open total mesorectal excision for rectal cancer: an evaluation of the mesorectum's macroscopic quality. Surg Endosc (2004) 0.87
The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer. World J Surg Oncol (2013) 0.86
Laparoscopic extraperitoneal rectal cancer surgery: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc (2011) 0.86
Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study. BMC Cancer (2014) 0.85
Techniques in total mesorectal excision surgery. Clin Colon Rectal Surg (2015) 0.85
TME quality in rectal cancer surgery. Eur J Med Res (2010) 0.85
Transanal total mesorectal excision: A valid option for rectal cancer? World J Gastroenterol (2015) 0.84
Metastatic lymph node ratio as a prognostic factor after laparoscopic total mesorectal excision for extraperitoneal rectal cancer. Surg Endosc (2012) 0.84
Prognostic value of lymph node ratio in survival of patients with locally advanced rectal cancer. Can J Surg (2015) 0.84
Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center. Int J Colorectal Dis (2009) 0.83
Nerve-oriented mesorectal excision (NOME): autonomic nerves as landmarks for laparoscopic rectal resection. Int J Colorectal Dis (2013) 0.83
Gender-specific acute organ toxicity during intensified preoperative radiochemotherapy for rectal cancer. Oncologist (2011) 0.82
Robotic Versus Laparoscopic Surgery for Rectal Cancer after Preoperative Chemoradiotherapy: Case-Matched Study of Short-Term Outcomes. Cancer Res Treat (2015) 0.81
Higher risk of incomplete mesorectal excision and positive circumferential margin in low rectal cancer regardless of surgical technique. Wideochir Inne Tech Maloinwazyjne (2014) 0.81
Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II study. Br J Cancer (2006) 0.81
10-Year Oncologic Outcomes After Laparoscopic or Open Total Mesorectal Excision for Rectal Cancer. World J Surg (2016) 0.81
Abdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection margin. World J Gastroenterol (2014) 0.81
Robotic total mesorectal excision for the treatment of rectal cancer. J Robot Surg (2007) 0.81
Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: do we have indications for individual risk stratification? World J Surg Oncol (2010) 0.80
Laparoscopic resection for rectal cancer: what is the evidence? Biomed Res Int (2014) 0.80
Quality management in rectal carcinoma: what is feasible? Int J Colorectal Dis (2009) 0.79
Robotic technology: Optimizing the outcomes in rectal cancer? World J Clin Oncol (2015) 0.79
Current status of laparoscopy for the treatment of rectal cancer. World J Gastroenterol (2014) 0.79
Surgical margins and short-term results of laparoscopic total mesorectal excision for low rectal cancer. JSLS (2013) 0.79
Pathologic processing of the total mesorectal excision. Clin Colon Rectal Surg (2015) 0.79
Robotic-Assisted Surgery Improves the Quality of Total Mesorectal Excision for Rectal Cancer Compared to Laparoscopy: Results of a Case-Controlled Analysis. World J Surg (2016) 0.78
Pre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative Chemoradiotherapy. Med Arch (2016) 0.78
Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades. Int J Colorectal Dis (2015) 0.78
Transanal Total Mesorectal Excision With Single-Incision Laparoscopy for Rectal Cancer. JSLS (2016) 0.78
International quality assurance project in colorectal cancer-unifying diagnostic and histopathological evaluation. Langenbecks Arch Surg (2014) 0.78
Robotic total mesorectal excision for rectal cancer: it may improve survival as well as quality of life. Surg Endosc (2008) 0.77
Thymidylate synthase as a prognostic biomarker for locally advanced rectal cancer after multimodal treatment. Ann Surg Oncol (2011) 0.77
Comparison of tumor recurrence between laparoscopic total mesorectal excision with sphincter preservation and laparoscopic abdominoperineal resection for low rectal cancer. Surg Endosc (2013) 0.77
Single-incision laparoscopic surgery for colorectal malignancy--results of a matched-pair comparison to conventional surgery. Int J Colorectal Dis (2014) 0.77
Surgical timing after chemoradiotherapy for rectal cancer, analysis of technique (STARRCAT): results of a feasibility multi-centre randomized controlled trial. Tech Coloproctol (2016) 0.77
Quality of surgical care, local recurrence, and survival in patients with low- and midrectal cancers following multimodal therapy. Int J Colorectal Dis (2011) 0.76
Colorectal Cancer Association of Canada consensus meeting: raising the standards of care for early-stage rectal cancer. Curr Oncol (2009) 0.76
Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications. Biomed Res Int (2015) 0.76
The modern anatomical surgical approach to localised rectal cancer. EJC Suppl (2013) 0.76
Robotic Surgery for Rectal Cancer: An Update in 2015. Cancer Res Treat (2016) 0.76
Optimised surgery (so-called TME surgery) and high-resolution MRI in the planning of treatment of rectal carcinoma. Langenbecks Arch Surg (2007) 0.76
Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer. Tech Coloproctol (2016) 0.76
The Impact of Postoperative Complications on Long-term Oncologic Outcomes After Laparoscopic Low Anterior Resection for Rectal Cancer. Medicine (Baltimore) (2016) 0.76
Transanal total mesorectal excision for rectal cancer: a preliminary report. Surg Endosc (2015) 0.75
Survival after surgical treatment of cancer of the rectum. Langenbecks Arch Surg (2004) 0.75
The implementation of a standardized approach to laparoscopic rectal surgery. JSLS (2013) 0.75
Mucinous adenocarcinoma of the umbilicus 8 years following anterior resection for villous adenoma of the rectum. J Surg Case Rep (2014) 0.75
Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol (2016) 0.75
Continuous intraoperative monitoring of pelvic autonomic nerves during TME to prevent urogenital and anorectal dysfunction in rectal cancer patients (NEUROS): a randomized controlled trial. BMC Cancer (2016) 0.75
Laparoscopic complete mesocolic excision with central vascular ligation in right colon cancer: A comprehensive review. World J Gastrointest Surg (2016) 0.75
Laparoscopy for Rectal Cancer. Clin Colon Rectal Surg (2017) 0.75
Robotic rectal surgery: State of the art. World J Gastrointest Oncol (2016) 0.75
German Bowel Cancer Center: An Attempt to Improve Treatment Quality. Gastroenterol Res Pract (2015) 0.75
Transanal Total Mesorectal Excision: A Novel Approach to Rectal Surgery. Clin Colon Rectal Surg (2017) 0.75
Sparing Sphincters and Laparoscopic Resection Improve Survival by Optimizing the Circumferential Resection Margin in Rectal Cancer Patients. Medicine (Baltimore) (2016) 0.75
Robotic Surgery for Colon and Rectal Cancer. Curr Oncol Rep (2016) 0.75
Prognostic relevant factors within pT3 rectal carcinomas: depth of invasion or circumferrential resection margins? Int J Colorectal Dis (2003) 0.75
The impact of general/visceral obesity on completion of mesorectum and perioperative outcomes of laparoscopic TME for rectal cancer: A STARD-compliant article. Medicine (Baltimore) (2016) 0.75
EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review. Virchows Arch (2014) 0.75
Prospective Randomized Study Comparing Robotic-Assisted Surgery with Traditional Laparotomy for Rectal Cancer-Indian Study. Indian J Surg (2013) 0.75
Pathologic evaluation of total mesorectal excision: big brother is watching. J Clin Oncol (2002) 0.75
Prediction of Anastomotic Leakage After Laparoscopic Low Anterior Resection in Male Rectal Cancer by Pelvic Measurement in Magnetic Resonance Imaging. Surg Laparosc Endosc Percutan Tech (2017) 0.75
The impact of shortened postgraduate surgical training on colorectal cancer outcome. Int J Colorectal Dis (2014) 0.75
Extended lymphadenectomy in rectal cancer is debatable. World J Surg (2013) 0.75
[Pathological work-up of rectal cancer following partial/total mesorectal excision]. Pathologe (2011) 0.75
Gastric cancer. Lancet (2009) 7.27
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol (2010) 6.60
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol (2011) 5.75
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet (2009) 4.58
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet (2008) 4.44
The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg (2007) 4.22
The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol (2011) 3.24
What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol (2008) 3.21
Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol (2002) 3.09
Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol (2013) 3.01
Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol (2011) 2.67
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial. J Clin Oncol (2011) 2.58
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial. Lancet Oncol (2013) 2.41
Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study. J Clin Oncol (2014) 2.39
Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol (2005) 2.33
Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol (2010) 2.29
External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer. J Natl Cancer Inst (2014) 2.26
Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study. J Clin Oncol (2012) 2.20
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysis. J Clin Oncol (2013) 2.17
Optical image-guided surgery--where do we stand? Mol Imaging Biol (2011) 2.15
Timing of the sentinel lymph node biopsy in breast cancer patients receiving neoadjuvant therapy - recommendations for clinical guidance. Eur J Surg Oncol (2013) 2.12
A multivariate analysis of limiting factors for stoma reversal in patients with rectal cancer entered into the total mesorectal excision (TME) trial: a retrospective study. Lancet Oncol (2007) 2.12
Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol (2002) 2.11
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis. Eur J Cancer (2012) 2.07
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest (2004) 2.05
Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol (2010) 2.04
Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA (2012) 2.00
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. J Clin Oncol (2007) 1.97
Intraoperative near infrared fluorescence guided identification of the ureters using low dose methylene blue: a first in human experience. J Urol (2013) 1.97
Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients. Breast Cancer Res Treat (2011) 1.89
Causes of fecal and urinary incontinence after total mesorectal excision for rectal cancer based on cadaveric surgery: a study from the Cooperative Clinical Investigators of the Dutch total mesorectal excision trial. J Clin Oncol (2008) 1.87
The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy. Ann Surg Oncol (2012) 1.87
Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat (2010) 1.83
Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. Eur J Endocrinol (2009) 1.78
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). BMC Cancer (2011) 1.76
Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol (2009) 1.74
Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination. J Clin Endocrinol Metab (2010) 1.72
Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer (2013) 1.71
EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol (2004) 1.68
The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol (2003) 1.68
Improved regional control and survival with "low Maruyama Index" surgery in gastric cancer: autopsy findings from the Dutch D1-D2 Trial. Gastric Cancer (2007) 1.67
Cellular angiofibroma: analysis of 25 cases emphasizing its relationship to spindle cell lipoma and mammary-type myofibroblastoma. Mod Pathol (2010) 1.67
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol (2009) 1.55
Optimal locoregional treatment in gastric cancer. J Clin Oncol (2005) 1.54
Aspirin use after diagnosis improves survival in older adults with colon cancer: a retrospective cohort study. J Am Geriatr Soc (2012) 1.51
Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol (2007) 1.50
Virtual reality microscope versus conventional microscope regarding time to diagnosis: an experimental study. Histopathology (2012) 1.47
Loss of membranous Ep-CAM in budding colorectal carcinoma cells. Mod Pathol (2007) 1.45
PIK3CA mutations predict local recurrences in rectal cancer patients. Clin Cancer Res (2009) 1.45
Metastases of colorectal carcinoma: comparison of soft- and hard-copy helical CT interpretation. Radiology (2003) 1.45
Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysis. J Mol Diagn (2012) 1.44
An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer. Int J Colorectal Dis (2011) 1.44
Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat (2011) 1.43
Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites. Leuk Lymphoma (2013) 1.43
Morphological quantification of emphysema in small human lung specimens: comparison of methods and relation with clinical data. Mod Pathol (2003) 1.42
HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. J Immunol (2010) 1.38
The ileo neo rectal anastomosis: long-term results of surgical innovation in patients after ulcerative colitis and familial adenomatous polyposis. Int J Colorectal Dis (2012) 1.38
Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer (2006) 1.38
Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization. Clin Cancer Res (2005) 1.38
Estimation and prediction in a multi-state model for breast cancer. Biom J (2006) 1.36
Detection of colorectal cancer using MALDI-TOF serum protein profiling. Eur J Cancer (2006) 1.36
Self-reports of health-care utilization: diary or questionnaire? Int J Technol Assess Health Care (2005) 1.35
Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles. BMC Genomics (2005) 1.34
Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. Cancer (2005) 1.34
Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience. Breast Cancer Res Treat (2013) 1.33
Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study. J Clin Oncol (2011) 1.31
Virtual reality Powerwall versus conventional microscope for viewing pathology slides: an experimental comparison. Histopathology (2009) 1.31
Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie. A review. Dis Colon Rectum (2008) 1.31
Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol (2002) 1.30
Lymph node retrieval in rectal cancer is dependent on many factors--the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol (2009) 1.29
The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer. Clin Cancer Res (2010) 1.28
Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer. Clin Cancer Res (2009) 1.27
Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer. J Surg Oncol (2005) 1.26
Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients. Ann Surg Oncol (2012) 1.26
Clinical translation of ex vivo sentinel lymph node mapping for colorectal cancer using invisible near-infrared fluorescence light. Ann Surg Oncol (2010) 1.24
The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer (2009) 1.24
Near-infrared fluorescence imaging of liver metastases in rats using indocyanine green. J Surg Res (2011) 1.23
A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status. Cancer (2009) 1.23
Optimization of near-infrared fluorescent sentinel lymph node mapping in cervical cancer patients. Int J Gynecol Cancer (2011) 1.22
Cost measurement in economic evaluations of health care: whom to ask? Med Care (2004) 1.22
Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol (2008) 1.20
Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg (2007) 1.20
Has the new TNM classification for colorectal cancer improved care? Nat Rev Clin Oncol (2011) 1.19
Tracking with virtual slides: a tool to study diagnostic error in histopathology. Histopathology (2009) 1.18
Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer (2012) 1.18
Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer. Breast Cancer Res Treat (2010) 1.17
p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases. Clin Exp Metastasis (2004) 1.17
Evaluation of a panel of expert pathologists: review of the diagnosis and histological classification of Hodgkin and non-Hodgkin lymphomas in a population-based cancer registry. Leuk Lymphoma (2013) 1.16
Biomarkers in precision therapy in colorectal cancer. Gastroenterol Rep (Oxf) (2013) 1.15
The relationship between volume or surgeon specialty and outcome in the surgical treatment of lung cancer: a systematic review and meta-analysis. J Thorac Oncol (2012) 1.15
A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg (2009) 1.14
USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. Radiology (2008) 1.14
Image-guided hepatopancreatobiliary surgery using near-infrared fluorescent light. J Hepatobiliary Pancreat Sci (2012) 1.14
Clinical implications of CYP2D6 genotyping in tamoxifen treatment for breast cancer. Clin Cancer Res (2009) 1.14